glp 1 super responders More than in 4 adults with obesity had a novel physiologic subtype marked by fast gastric emptying, discordantly low postmeal GLP‑1 levels, and increased postmeal hunger. In a retrospective analysis, participants GLP-1 Hyper-Responders: The Good, The

With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures

Myopathies of endocrine disorders: A prospective clinical and biochemical study

Myth #5: Higher Doses Always Work Better Fact: Research doesn't support the assumption that doubling or tripling the dose proportionally increases benefits

Researchers not involved in the study said it adds to the growing body of research on possible benefits of GLP-1 drugs commonly prescribed for weight loss and to treat Type 2 diabetes

doi: 10.1007/s00401-021-02266-7 51 FaganA